The 20 Best Plasmacytoma Doctors near San Francisco, CA

A leading expert in hematology-oncology, Dr. Thomas Martin is associate director of UCSF's myeloma program and director of the unrelated donor transplantation programs for adults at UCSF Medical Center. Martin is clinical research director of hematologic malignancies (blood cancers) at the UCSF Helen Diller Family Comprehensive Cancer Center. His research interests include developing treatments for myeloma and leukemia as well as expanding the use of bone marrow transplants. He has a special interest in umbilical cord blood transplants, and he is involved in efforts to improve outcomes for patients who have transplants from unrelated donors. Martin earned an undergraduate degree at Cornell University and his medical degree at the University of Connecticut School of Medicine. After a medical residency at Harbor-UCLA Medical Center, he completed a fellowship in hematology-oncology at UCSF. In 1999, he joined MD Anderson Cancer Center as an assistant professor of medicine. In 2001, he returned to UCSF. Dr. Martin is rated as an Advanced provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Dr. Steve Braunstein is a radiation oncologist who cares for both adult and pediatric patients. He specializes in treating brain and spinal tumors, sarcomas, lymphoma and pediatric cancers. He also provides palliative radiotherapy to reduce symptoms in patients with advanced cancer. His expertise encompasses a number of technologies that use radiation as therapy, with a special focus on intraoperative radiotherapy and radiosurgery – using targeted high-dose radiation to destroy tumors, either as an alternative to surgical procedures or in combination with them. Braunstein's primary areas of research include improving radiation planning and treatment through the use of both gene marker analysis and advanced imaging technologies. He also studies how to improve the coordination, timing and delivery of health care that involves a variety of disciplines, including symptom management and cancer specialties. After earning his medical degree as well as a doctorate in biomedical sciences at New York University School of Medicine, Braunstein completed a residency in radiation oncology at UCSF. Braunstein is program director of UCSF's residency program and has a special interest in educating residents and medical students. He received a UCSF Medical Center Exceptional Physician Award in 2013. Braunstein serves as an editor for the International Journal of Radiation Oncology, Biology and Physics. He belongs to the American Society for Radiation Oncology, American Society of Clinical Oncology, Children's Oncology Group, Radiological Society of North America, North American Skull Base Society, International Gamma Knife Research Foundation and International Stereotactic Radiosurgery Society. He is active on committees within the National Cancer Institute, Children's Oncology Group and NRG Oncology. Dr. Braunstein is rated as an Experienced provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Meningioma, Brain Tumor, Posterior Fossa Tumor, Gamma Knife Radiosurgery, and Osteotomy.

Dr. Shagun Arora is a hematologist-oncologist who specializes in caring for patients with malignant and classical (cancerous and noncancerous) blood disorders. She treats patients with diverse hematologic conditions in both categories. Her focus is monoclonal gammopathies, or conditions in which the blood contains abnormal proteins, including MGUS (monoclonal gammopathy of undetermined significance) and multiple myeloma, along with anemias. Arora's goal is to provide compassionate, supportive care that takes the whole person into consideration, while helping patients fight cancer. She considers it a privilege to be part of the lives of cancer patients and their families. In addition to patient care, she is passionate about medical education, working closely with training physicians who are pursuing fellowships in hematology and oncology. Arora is the medical director of the Infusion Center at UCSF's Parnassus campus. Arora completed her residency at Michigan State University, followed by a fellowship at MedStar Washington Hospital Center and MedStar Georgetown University Hospital, where she served as chief fellow. She is a member of several professional associations, including the American Society of Hematology, American Society of Clinical Oncology, Society of Hematologic Oncology and International Myeloma Society. In her free time, Arora enjoys international travel, yoga retreats and hiking to view the gorgeous vistas of San Francisco. Dr. Arora is rated as an Experienced provider by MediFind in the treatment of Plasmacytoma. Her top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Marrow Aspiration.

Dr. James Rubenstein is a hematologist-oncologist, or a specialist in blood disorders. He has particular expertise in treating patients with neurologic complications from cancer, including patients with non-Hodgkin's lymphoma involving the brain (called central nervous system lymphoma). He also specializes in patients with cancer that has spread to the brain from other parts of the body. In his research, Rubenstein investigates immunologic tools to improve tumor response to chemotherapy and radiation treatment, and to minimize toxicity from treatment. He is also interested in developing tumor biomarkers to diagnose brain tumors. Rubenstein earned his medical degree at Weill Cornell Medicine and completed a residency in internal medicine at Stanford Medicine. He earned a doctorate in molecular and cellular neurosciences at the Rockefeller University. He completed a fellowship in hematology and oncology at UCSF, which included training in neuro-oncology. Rubenstein has won research awards from the Leukemia & Lymphoma Society and the National Cancer Institute. He is a member of the American Society of Hematology, American Society of Clinical Oncology and American Association for Cancer Research. Dr. Rubenstein is rated as an Experienced provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Primary Lymphoma of the Brain, Non-Hodgkin Lymphoma, Gastric Lymphoma, Vitrectomy, and Bone Marrow Aspiration.

Dr. Jeffrey L. Wolf is a hematologist with expertise in cancers of the bone marrow and blood, as well as in bone marrow transplantation to treat these cancers. His primary focus in both patient care and research is myeloma, the second most common blood cancer. He directs UCSF's Multiple Myeloma Program and the Stephen and Nancy Grand Multiple Myeloma Translational Initiative – a program to support the development of better treatments – at the UCSF Helen Diller Family Comprehensive Cancer Center. Wolf's current research interests are in measuring minimal residual disease in patients who have undergone successful treatment for myeloma, as the results are useful in predicting long-term survival. Wolf earned his medical degree at the University of Illinois College of Medicine at Chicago and completed a residency in medicine at the University of California, San Diego. He completed a fellowship in hematology and oncology at UCSF, followed by a bone marrow transplantation rotation at the Fred Hutchinson Cancer Research Center. In 1979, Wolf helped establish the bone marrow transplant program at the City of Hope Comprehensive Cancer Center in Duarte, California. In 1984, he helped establish the first bone marrow transplant unit based at a community hospital in the United States, at Alta Bates Summit Medical Center in Berkeley. He joined UCSF in 2007. Dr. Wolf is rated as an Experienced provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Dr. Lawrence D. Kaplan, a hematologist-oncologist, directs UCSF's lymphoma program. He is an international leader in the treatment of lymphoma and HIV-associated lymphoma. In his research, Kaplan is particularly interested in developing new treatments for lymphoma and the HIV-related form of this cancer. Kaplan earned his medical degree at the David Geffen School of Medicine at UCLA. He completed a residency in medicine at Boston Medical Center and completed a fellowship in hematology and oncology at UCSF. He joined UCSF in 1985. Kaplan's professional activities include serving on the Lymphoma Working Group of the AIDS Malignancy Consortium, a clinical trials group supported by the National Cancer Institute (NCI). He formerly chaired the group's steering committee. He also serves on the lymphoma committee of Alliance for Clinical Trials in Oncology, a national research group sponsored by the NCI. Dr. Kaplan is rated as an Experienced provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.

Ajai Chari is an Oncologist in San Francisco, California. Dr. Chari is rated as an Experienced provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Nina Shah is an Oncologist in San Francisco, California. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Plasmacytoma. Her top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Lloyd Damon is an Oncologist in San Francisco, California. Dr. Damon has been practicing medicine for over 44 years and is rated as an Experienced provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Gordon Wong is a Radiation Oncologist in San Francisco, California. Dr. Wong is rated as an Experienced provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Intraductal Papilloma, and Astrocytoma.

Pyone Soe is a primary care provider, practicing in Internal Medicine in San Francisco, California. Dr. Soe is rated as an Experienced provider by MediFind in the treatment of Plasmacytoma. Her top areas of expertise are Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Vertigo, and Jaundice.

Oleg Krijanovski is a Hematologist in Berkeley, California. Dr. Krijanovski is rated as an Advanced provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Thrombocytopenia, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration. Dr. Krijanovski is currently accepting new patients.

Dr. Sophia Rahman is a radiation oncologist who cares for patients with cancer. She is especially focused on caring for patients with breast cancer, lung cancer, or head and neck cancer. Rahman earned her medical degree from the David Geffen School of Medicine at the University of California, Los Angeles. She completed residencies in internal medicine and radiation oncology at Kaiser Permanente. Dr. Rahman is rated as an Experienced provider by MediFind in the treatment of Plasmacytoma. Her top areas of expertise are Intraductal Papilloma, Nasopharyngeal Carcinoma, Lung Cancer, Pleuropulmonary Blastoma, and Gamma Knife Radiosurgery.

Dr. Sravana K. Chennupati is a radiation oncologist whose care centers on working closely with patients and their families to understand their individual needs and priorities. He is committed to providing compassionate, personalized and high-quality cancer treatment. Partnering with a team of specialists from many disciplines, he coordinates care to deliver the safest and most effective treatments using highly advanced technologies. Chennupati earned his medical degree at Stanford University School of Medicine, with a concentration in community health and public service. He completed a residency in radiation oncology at Oregon Health and Science University, where he served as chief resident. Outside the clinic, Chennupati enjoys spending time with his family, cooking, being outdoors, trying new restaurants, reading and traveling. Dr. Chennupati is rated as an Experienced provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Lung Cancer, and Pleuropulmonary Blastoma.

Dr. James L. Rembert is a radiation oncologist who specializes in treating various types of cancer, brain and spinal cord tumors, cancers of the reproductive and urinary systems, lung cancers and other cancers in the chest, and bone or soft tissue tumors (sarcomas). His path to becoming a radiation oncologist began with personal tragedy, losing both his brother and a friend to cancer while in college. These experiences ignited his passion for oncology and shaped his approach to patient care. Understanding the challenges firsthand, he strives to treat each patient and their family with empathy and compassion. Rembert earned his medical degree from the Perelman School of Medicine at the University of Pennsylvania. He completed a residency in radiation oncology at UCSF. Dr. Rembert is rated as an Experienced provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Embryonal Tumor with Multilayered Rosettes, and Gliosarcoma.

Dr. Christine Chung is a radiation oncologist who specializes in caring for patients with breast cancer or skin cancer. Chung earned her bachelor's degree from Harvard College. At Harvard Medical School, she earned her medical degree and completed her residency in radiation oncology, where she served as chief resident. She also has a master of public health degree from the Harvard T.H. Chan School of Public Health. Chung has served in a variety of leadership and educational positions in her field. She is on the professional advisory board for the Cancer Support Community and serves as an examiner for the breast section of the American Board of Radiology oral board exam. She was named a fellow of the American Society for Radiation Oncology in 2024. Chung has trained professionally in ballet and modern dance. In her free time, she enjoys playing the piano, reading novels, and playing tennis with her husband and two kids. Dr. Chung is rated as an Experienced provider by MediFind in the treatment of Plasmacytoma. Her top areas of expertise are Breast Cancer, Angiosarcoma, Pleuropulmonary Blastoma, and HER-2 Positive Breast Cancer.

Rajesh Behl is an Oncologist in Berkeley, California. Dr. Behl is rated as an Advanced provider by MediFind in the treatment of Plasmacytoma. His top areas of expertise are Waldenstrom Macroglobulinemia, Schnitzler Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), Multiple Myeloma, and Bone Marrow Aspiration.